170370 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates; Assays involving proteins of known structure or function as defined in the subgroups; Details; Regulators; Modulating activity Inhibitors; Supressors
BIOMARKERS IN LONG-COVID-19
#2Bcl2 Family in Dysfunctional Neurons Is Critical to the Evolution, Diagnosis and Treatment of Neurodegenerative Diseases Including but Not Limited to Corticobasal Degeneration, Chronic Traumatic Encephalopathy, Amyotrophic Lateral Sclerosis (Als), Alzheimer's Disease, Parkinson's Disease, Down's Syndrome Dementia, and Lewy Body Dementia
#3BIOMARKER PANEL, MICROFLUIDIC DEVICE AND DETECTION KIT FOR CAPTURING CIRCULATING TUMOR CELLS
#4BIOMARKERS FOR DETECTING AND MONITORING BREAST CANCER
#5EXTRACELLULAR VESICLES-BASED BIOMARKERS FOR PANCREATIC CANCER
#6MARKERS OF TOTIPOTENCY AND METHODS OF USE
#7TARGETING S100A9-ALDH1A1-RETINOIC ACID SIGNALING TO SUPPRESS BRAIN RELAPSE IN EGFR-MUTANT LUNG CANCER
#8APPLICATION OF BIOMARKER IN PREPARING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE CLASSIFICATION PRODUCTS
#9Methods and Compositions for Oral Cancer Risk
#10METHODS RELATING TO IMPAIRED RESPIRATORY HEALTH THERAPEUTICS
#11NOVEL USE OF ANTICANCER AGENT PRODRUG CONJUGATE
#12PHOSPHO-TAU ANTIBODIES AND METHODS OF USE
#13ORAL MESENCHYMAL STEM CELLS AND USE THEREOF
#14NUCLEOPHOSMIN PROTEIN (NPM) MUTANTS, CORRESPONDING GENE SEQUENCES AND USES THEREOF
#15Methods and Compositions for Evaluating Biomarkers in Salivary Exosomes and Evaluating Cognitive Fatigue
#16METHODS AND DEVICES FOR DETECTION OF ORTHOGONAL CLASSES OF DISEASE BIOMARKERS
#17PHOSPHOPEPTIDE/PHOSPHOPROTEIN SIGNATURE PREDICTING BASAL-LIKE BREAST CANCER RECURRENCE
#18BIOMARKERS AND THEIR USE IN DIAGNOSING PARKINSON'S DISEASE, VITREORETINAL DISEASES, AND AGE-RELATED PATHOLOGIES
#19METHODS FOR TREATING CELLULAR INFLAMMATION INDUCED BY AFB1
#20ANTI-POLYUBIQUITIN MULTISPECIFIC ANTIBODIES
#21PHOSPHO-TAU ANTIBODIES AND METHODS OF USE
#22COMPOSITIONS AND METHODS FOR ASSESSING AND TREATING AGE-RELATED CONDITIONS
#23Phospho-TAU antibodies and methods of use
#24A METHOD OF PREDICTING RISK OF AN AGGRESSIVE OR RECURRENT CANCER
#25Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
#26INHIBITOR FOR CHRONIC MYELOID LEUKEMIA STEM CELLS
#27NUCLEIC ACID BIOMARKER AND USE THEREOF
#28METHODS OF TREATMENT AND DIAGNOSTIC OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH INTENSE STRESS
#29TDP-43 BIOSENSOR CELL LINES
#30METHOD AND REAGENT FOR DETECTING PANCREATIC CANCERS
#31NUCLEOPHOSMIN PROTEIN (NPM) MUTANTS, CORRESPONDING GENE SEQUENCES AND USES THEREOF
#32DEVICES, ASSAYS AND METHODS OF TESTING PREECLAMPSIA
#33Assays and methods for targeted treatment of hydrosalpinx
#34METHOD FOR PREDICTION OF THE PROGRESSION RISK OF TUMORS
#35METHOD AND REAGENT FOR DETECTING MALIGNANT OVARIAN TUMORS
#36HSD17B13 variants and uses thereof
#37NOVEL CTHRC1-SPECIFIC ANTIBODY AND USE THEREOF
#38IMMUNOASSAY METHOD FOR FREE AIM IN BIOLOGICAL SAMPLE
#39Inter-alpha inhibitor proteins
#40SEROLOGICAL BIOMARKERS FOR EARLY DIAGNOSIS OF LUNG CANCER
#41METHODS FOR DETERMINING DRUG EFFICACY FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA, MULTIPLE MYELOMA, AND MYELOID CANCERS
#42SCREENING ASSAY
#43METHOD FOR DETECTING VIRAL LIVER CANCER
#44COMPOSITIONS TARGETING THE SOLUBLE EXTRACELLULAR DOMAIN OF E-CADHERIN AND RELATED METHODS FOR CANCER THERAPY
#45Biomarkers for the diagnosis of invasive fungal infections
#46METHODS, KITS AND COMPOSITIONS FOR CHARACTERIZING AN ANTI-INFLAMMATORY RESPONSE OF A PRODUCT
#47METHODS OF DETERMINING INTERFERON HAVING DIRECT INHIBITORY EFFECTS ON TUMORS AND USES THEREOF
#48METHODS OF EVALUATING TREATMENT OUTCOME IN HIGH GRADE SEROUS OVARIAN CANCER
#49MARKERS OF TOTIPOTENCY AND METHODS OF USE
#50DIAGNOSTIC AND DRUG SCREENING FOR MOLECULAR SIGNATURES OF EARLY ONSET SPORADIC PARKINSON'S DISEASE
#51METHOD FOR DETECTING AN ANTIGEN-SPECIFIC ANTIBODY AND REAGENT FOR USE THEREIN
#52PKC PATHWAY IN PARKINSON'S DISEASE
#53BIOMARKER COMBINATION FOR IDENTIFICATION OF "AT-RISK" SUBJECTS FOR AKI
#54IMMUNOGENIC COMPOSITIONS AND USES THEREFOR
#55miRNA biogenesis in exosomes for diagnosis and therapy
#56Antibodies specific for sclerostin and methods for increasing bone mineralization
#57Nucleic acid biomarker and use thereof
#58METHODS FOR QUANTIFYING INTER-ALPHA INHIBITOR PROTEINS
#59Neurofibromin/dopamine signaling as a biomarker for cognitive and behavioral problems in children with neurofibromatosis type 1 (NF1 )
#60NUCLEOPHOSMIN PROTEIN (NPM) MUTANTS, CORRESPONDING GENE SEQUENCES AND USES THEREOF
#61Tumor suppressor REC8 as a biomarker for gastric cancer
#62System and method for detection of trauma
#63COMPOSITIONS TARGETING THE SOLUBLE EXTRACELLULAR DOMAIN OF E-CADHERIN AND RELATED METHODS FOR CANCER THERAPY
#64ASSAYS AND METHODS FOR DETECTION AND TARGETED TREATMENT OF HYDROSALPINX
#65Methods for detection, staging, and surveillance of colorectal adenomas and carcinomas
#66Trefoil family factor proteins and uses thereof
#67Kisspeptin-54 detection by tandem mass spectrometry
#68SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein
#69METHOD FOR QUANTITATIVE ASSESSMENT IN BIOLOGICAL SAMPLE OF THE PHOSPHORYLATED AND NON-PHOSPHORYLATED FORM OF RKIP
#70Analysis of amino acids in body fluid by liquid chromotography-mass spectrometry
#71BIOMARKERS AND DIFFERENTIAL DIAGNOSIS OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS
#72PROGNOSIS OF SEROUS OVARIAN CANCER USING BIOMARKERS
#73Detection of angiopoietin-2 and thrombospondin-2 in connection with diagnosing acute heart failure
#74Methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancers
#75TDP-43 in degenerative disease
#76Tumor suppressor REC8 as a biomarker for gastric cancer
#77Methods and compositions relating to proteasome inhibitor resistance
#78KITS FOR STRATIFYING SCOLIOTIC SUBJECTS
#79Antibody that binds to human programmed death ligand 2 (PD-L2) and uses thereof
#80Using phage epitopes to profile the immune response
#81Biomarkers of myocardial injury
#82HSD17B13 variants and uses thereof
#83Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapy
#84BIN1 expression as a marker of cancer
#85Methods of determining interferon having direct inhibitory effects on tumors and uses thereof
#86Cell-based assay for determining mTOR activity
#87Kisspeptin-54 detection by tandem mass spectrometry
#88Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof
#89ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION
#90Methods for the diagnosis and treatment of Sjögren's syndrome
#91Mutant smoothened and methods of using the same
#92CKAP4-molecular-targeted antitumor agent
#93Identification of a 5-Gene Expression Signature Predicting Clinical Outcome of Patients with Brain Tumors
#94Methods of selecting compstatin mimetics
#95IMPROVED TREATMENTS OF CANCER RESISTANT TO TAXOIDS
#96METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#97SLFN11 AS BIOMARKER FOR AML
#98Tumor antigen peptide
#99Biomarker FOXF2 for gastric cancer
#100Use of EI24 gene
#101Kit for rapidly testing myocardial infarction and a preparation method and an application thereof
#102Trefoil family factor proteins and uses thereof
#103Method of treating BCL-2 over-expressing disorders using arts containing a BH3-like domain
#104Pharmaceutical combination comprising a CIP2A silencing agent for use in the treatment of a hyperproliferative disorder, preferably one with impaired P53 function
#105METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#106NEUROFIBROMIN/DOPAMINE SIGNALING AS A BIOMARKER FOR COGNITIVE AND BEHAVIORAL PROBLEMS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1)
#107Biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disorders
#108TREATMENT OF HODGKIN'S LYMPHOMA USING AN ANTI-PD-1 ANTIBODY
#109SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein
#110SRM/MRM assay for subtyping lung histology
#111METHODS FOR DETERMINING DRUG EFFICACY FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA, MULTIPLE MYELOMA, AND MYELOID CANCERS
#112Methods for diagnosing osteoarthritis
#113Semaphorin 3A as a diagnostic marker for urothelial cancer
#114MARKERS ASSOCIATED WITH HUMAN DOUBLE MINUTE 2 INHIBITORS
#115Proteasome inhibition assay and methods of use
#116Methods, Systems and Kits of Fecal NGal Rapid Immunochromatographic Test
#117A high-throughput assay to identify molecules that modulate Rb-E2F binding
#118USE OF ARPIN A NEW INHIBITOR OF THE ARP2/3 COMPLEX FOR THE DIAGNOSIS AND TREATMENT OF DISEASES
#119Dickkopf (DKK) Proteins as Biomarkers for Cognitive Decline Associated with Alzheimer's Disease
#120B7-H1 AND B7-H4 IN CANCER
#121METHOD FOR SCREEING CANCER METASTASIS INHIBITOR USING CULTURE OF CELLS OR SPHEROIDICALLY AGGREGATED CELLS IN WHICH LYSYL-TRNA SYNTHETASE IS REGULATED TO BE EXPRESSED OR UNEXPRESSED
#122GI PROTEIN PHOSPHORYLATION AS MARKER FOR SCOLIOSIS AND SCOLIOSIS PROGRESSION, METHODS OF INCREASING GIPCR SIGNALING IN SCOLIOTIC SUBJECTS
#123Biomarker of rehospitalization after heart failure
#124METHOD FOR MONITORING METASTASIS OF CANCER CELLS USING CELLS CULTURED IN THREE DIMENSIONAL COLLAGEN ENVIRONMENT
#125Methods for diagnosis and treatment of amyotrophic lateral sclerosis based on an increased level of interaction between TDP-43 polypeptide and NF-KB P65 polypeptide
#126Biomarkers for inflammatory bowel disease with ankylosing spondylitis
#127Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#128SRM/MRM assay for subtyping lung histology
#129COMPOSITIONS TARGETING THE SOLUBLE EXTRACELLULAR DOMAIN OF E-CADHERIN AND RELATED METHODS FOR CANCER THERAPY
#130Using phage epitopes to profile the immune response
#131METHODS AND COMPOSITIONS USEFUL IN MANIPULATING THE STABILITY OF RE1 SILENCING TRANSCRIPTION FACTOR
#132Systems And Methods For Early Detection Of Cervical Cancer By Multiplex Protein Biomarkers
#133miRNA BIOGENESIS IN EXOSOMES FOR DIAGNOSIS AND THERAPY
#134Treatment of insulin resistance associated with prolonged physical inactivity
#135Aminoheteroaryl compounds as MTH1 inhibitors
#136Methods and compositions for treating and identifying compounds to treat age-related macular degeneration treatment
#137Methods and Compositions for the Diagnosis of a Thyroid Condition
#138CTHRC1 RECEPTOR AND METHODS OF USE THEREOF
#139Methods for classifying a cancer as susceptible to TMEPAI-directed therapies and treating such cancers
#140Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof
#141METHODS FOR DETERMINING PARP INHIBITOR AND PLATINUM RESISTANCE IN CANCER THERAPY
#142PREDICTIVE BIOMARKERS FOR PRE-MALIGNANT BREAST LESIONS
#143Identification of a 5-Gene Expression Signature Predicting Clinical Outcome of Patients with Brain Tumors
#144ANTI-MIF ANTIBODY CELL MIGRATION ASSAY
#145CYLINDRINS AS ETIOLOGIC AGENTS OF AMYLOID DISEASES
#146COMPOSITION COMPRISING GRIM-19 AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING OBESITY OR LIPID-RELATED METABOLIC DISEASES
#147iASPP phosphorylation and metastatic potential
#148METHODS FOR DETERMINING RESISTANCE AGAINST MOLECULES TARGETING PROTEINS
#149Methods for the diagnosis and treatment of sjögren's syndrome
#150Isolated cardiac stem cells and methods of their use
#151Prodefensin-A6 assay method for the in vitro diagnosis of colorectal cancer
#152MARKER ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS
#153Semaphorin 3A for treatment and assessment of severity of Asthma
#154Diagnosis and treatment of brain tumor
#155Lipocalin-2 as a Biomarker for Pneumococcal Infection Status and Uses Thereof
#156Biomarkers for subtypes of cervical cancer
#157Antibodies specific for sclerostin and methods for increasing bone mineralization
#158Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof
#159DETERMINATION OF EFFICIENT TIME(S) FOR CHEMOTHERAPY DELIVERY
#160MARKER PEPTIDES FOR DETERMINING THE OCCURRENCE OF AN INFLAMMATORY STATE IN A SUBJECT
#161Methods of predicting and decreasing the risk of pre-term birth
#162METHODS AND COMPOSITIONS FOR REGULATING MUSASHI FUNCTION
#163NUCLEIC ACID BIOMARKER AND USE THEREOF
#164TREFOIL FAMILY FACTOR PROTEINS AND USES THEREOF
#165Kisspeptin-54 detection by tandem mass spectrometry
#166BIOMARKER FOR EARLY NEURODEGENERATION DETECTION
#167METHOD FOR PREDICTION OF THE PROGRESSION RISK OF TUMORS
#168METHOD AND KIT FOR DETECTION OF ANTI-BETA AMYLOID ANTIBODIES
#169BIOMARKERS OF PULMONARY HYPERTENSION
#170Method for producing reagent for antibody detection and use thereof
#171Monoclonal antibodies and diagnostic uses thereof
#172METHOD FOR IDENTIFYING A SUBJECT AT RISK OF DEVELOPING HEART FAILURE BY DETERMINING THE LEVEL OF GALECTIN-3 OR THROMBOSPONDIN-2
#173ANTAGONISTS OF Bcl-2 AND USES THEREOF IN INDUCTION OF APOPTOSIS
#174BIN1 expression as a marker of cancer
#175Transcriptional repression leading to parkinson's disease
#176ERAP1-derived peptide and use thereof
#177Kisspeptin-54 detection by tandem mass spectrometry
#178ASPP2 splicing variant
#179Antibodies specific for sclerostin and methods for increasing bone mineralization
#180Antibodies specific for sclerostin and methods for increasing bone mineralization
#181Combination methods for treatment of disease
#182Monoclonal antibodies and diagnostic uses thereof
#183Antibodies specific for sclerostin and methods for increasing bone mineralization
#184Construct for producing empty virus capsids
#185Marker associated with non-alcoholic steatohepatitis
#186METHOD FOR IDENTIFYING A SUBJECT AT RISK OF DEVELOPING HEART FAILURE BY DETERMINING THE LEVEL OF GALECTIN-3 OR THROMBOSPONDIN-2
#187Tumor suppressor killin
#188Prodefensin-A6 assay method for the in vitro diagnosis of colorectal cancer
#189Methods for determining agents that treat or prevent obesity and/or obesity related diseases and methods for treatment therewith
#190Transcriptional repression leading to Parkinson's disease
#191Prohibitin as target for cancer therapy
#192MARKER PEPTIDES FOR DETERMINING THE OCCURRENCE OF AN INFLAMMATORY STATE IN A SUBJECT
#193Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#194Arrestin biosensor
#195USING PHAGE EPITOPES TO PROFILE THE IMMUNE RESPONSE
#196Biomarkers for subtypes of cervical cancer
#197Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
#198ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION
#199Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
#200TAT-BASED IMMUNOMODULATORY COMPOSITIONS AND METHODS FOR THEIR DISCOVERY AND USE
#201Method for prediction of the progression risk of tumors
#202BRIDGED SECONDARY AMINES AND USE THEREOF AS IAP BIR DOMAIN BINDING COMPOUNDS
#203TUMOR SUPPRESSION THROUGH PLEXIN C1
#204EYA2S As Modifiers of the PTEN/AKT Pathway and Methods of Use
#205METHODS AND COMPOSITIONS FOR TREATING T-CELL LEUKEMIA
#206Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
#207Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, bcl-2 and caspase-3
#208Methods and compositions for treating and identifying compounds to treat age-related macular degeneration
#209ANTAGONIST AGAINST TOLERANCE TO ANTICANCER DRUGS
#210Tumor Suppressor Killin
#211Methods and products for neutralizing the harmful effects of combustion products
#212GALK1S AS MODIFIERS OF THE PTEN/AKT PATHWAY AND METHODS OF USE
#213CDC6S AS MODIFIERS OF THE PTEN/AKT PATHWAY AND METHODS OF USE
#214Method for screening anti-HIV Drugs and a diagnostic method of AIDS
#215METHODS FOR DIAGNOSING OSTEOARTHRITIS
#216Use of melanoma inhibitory activity (MIA) protein as an early indicator for therapeutic response in melanoma
#217DIAGNOSTIC USES OF FOLLISTATIN-LIKE 1
#218Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof
#219Injectable Combination Therapy for Eye Disorders
#220B7-H1 AND B7-H4 IN CANCER
#221RORS as modifiers of the p21 pathway and methods of use
#222JAB1 as a prognostic marker and a therapeutic target for human cancer
#223Immunogenic peptides derived from sclerostin
#224SEMA4D in cancer diagnosis, detection and treatment
#225Biomarker for sensitivity to mTOR inhibitor therapy in kidney cancer
#226Methods and compositions relating to promoter regulation by MUC1 and KLF proteins
#227Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof
#228Selective and dual-action p53/MDM2/MDM4 antagonists
#229Antagonist Against Tolerance to Anticancer Drugs
#230Increasing life span by modulation of Smek
#231Prohibitin as Target for Cancer Therapy
#232Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
#233SUPPRESSION OF INHIBITORS
#234Tat-based immunomodulatory compositions and methods of their discovery and use
#235Compositions for Inhibiting plexin-A1-DAP12 interactions and Methods of Treating Inflammatory, Autoimmune or Bone Resorption Diseases Using the Same
#236Methods of treating age-related macular degeneration by compstatin and analogs thereof
#237Method for Increasing the Yield of Proliferating Primary Keratinocytes
#238Diagnostic marker for interferon responsiveness in multiple sclerosis
#239Rabbit monoclonal antibodies against mouse/human Id3 proteins
#240Loc169505 as modifiers of the apc and axin pathways and methods of use
#241Flj10607 as modifier of the axin pathway and methods of use
#242Prohibitin-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance
#243Biomarker for determining predisposition and/or prognosis of hepatocellular carcinoma
#244Method of determining efficacy of anticancer drug and determination kit therefor
#245Use of azetidinone compounds
#246Tumor suppressor Killin
#247USE OF BRCA1-ASSOCIATED PROTEIN TO TREAT AND SCREEN FOR DNA DAMAGE AND TO IDENTIFY THERAPEUTICS THAT PROMOTE A DNA DAMAGE RESPONSE
#248Compositions and methods of use of Semaphorin 3F and antagonists thereof in the stimulation of neuromuscular regeneration and treatment of muscular diseases
#249TREATMENT OF PROLIFERATIVE DISORDERS
#250Use of compounds capable of inhibiting the proteolytic processing of semaphorins for prevention, treatment, diagnosis and prognosis of an invasive disease
#251Rors as modifiers of the p21 pathway and methods of use
#252Screening methods for inhibitors of protein-protein binding interactions
#253Increasing life span by modulation of Smek
#254Maxs as modifiers of the axin pathway and methods of use
#255Use of azetidinone compounds
#256Tat-based immunomodulatory compositions and methods for their discovery and use
#257Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP
#258Pappss as modifiers of the axin pathway and methods of use
#259Smooth muscle growth inhibitory composition, diagnostic method for arteriosclerosis, and kit therefor
#260Antibodies specific for sclerostin and methods of screening and use therefor
#261JAB1 as a prognostic marker and a therapeutic target for human cancer
#262Tumor suppressor designated Hippo
#263Human ARL-related gene variants associated with cancers